Concurrent Sweet’s syndrome and myopericarditis following mesalamine therapy

Mesalamine, or 5-aminosalicylic acid, is a frequently used medication for the treatment of inflammatory bowel disease (IBD). We report the case of a 40-year-old woman recently diagnosed with IBD and started on mesalamine, who presented with new onset tender skin lesions 3 days following medication a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Case Rep
Päätekijät: Shabtaie, Samuel A, Tan, Nicholas Y, Parikh, Riddhi S, Papadakis, Konstantinos A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2018
Aiheet:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878295/
https://ncbi.nlm.nih.gov/pubmed/29574433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223851
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia